Previous 10 | Next 10 |
EDWARDS PASCAL PRECISION TRANSCATHETER VALVE REPAIR SYSTEM RECEIVES FDA APPROVAL FOR DEGENERATIVE MITRAL REGURGITATION PR Newswire IRVINE, Calif. , Sept. 15, 2022 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW), today announced the compan...
EDWARDS LAUNCHES SAPIEN 3 ULTRA RESILIA VALVE FOLLOWING FDA APPROVAL PR Newswire IRVINE, Calif. , Sept. 12, 2022 /PRNewswire/ -- Edwards Lifesciences (NYSE: EW) today announced the launch of the SAPIEN 3 Ultra RESILIA valve, which incorporates Edwards' br...
Summary Bridgewater Associates’ 13F portfolio value decreased from ~$24.81B to ~$23.60B this quarter. They increased Walmart and CVS Health while dropping Alibaba and JD.com. The top three individual stock positions are Procter & Gamble, Johnson & Johnson, and C...
EDWARDS PASCAL PRECISION TRANSCATHETER MITRAL AND TRICUSPID VALVE REPAIR SYSTEM RECEIVES CE MARK PR Newswire IRVINE, Calif. , Aug. 17, 2022 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW), today announced the company's PASCAL Precision transca...
On August 15, institutional investment managers with more than $100 million AUM had to disclose their positions at the end of Q2 2022. I curated a list of some high-profile hedge funds and looked into their holdings at the end of June 2022. June was a temporary bottom in the marke...
Momentum's shift into the Health Care sector proved ill-timed last May. Edwards Lifesciences has outperformed lately, but shares are not cheap, and the technical picture is somewhat bearish. An upcoming conference could spark share price volatility. The momentum factor w...
Fisher’s 13F portfolio value decreased from ~$165B to ~$141B in Q2 2022. Johnson & Johnson and Capital One Financial were increased while reducing Eli Lilly and Novo Nordisk this quarter. The top three positions are Apple, Microsoft, and Amazon. They add up to ~15% of t...
Analysis of the top ten pharma and medical device companies shows a 2% advantage for medical device on a total return basis over the last ten years. There are many possible reasons for this difference but patent cliffs and litigation are problems for Pharma. Investors seeking supe...
Avaya Holdings ( AVYA ) -23% on disappointing Q3 prelim results. Roku ( ROKU ) -21% as analysts rush to downgrade following Q2 miss, weak guidance. DexCom ( DXCM ) -13% on Q2 results. Intel ( INTC ) -12% on Q2 results. Cr...
Image source: The Motley Fool. Edwards Lifesciences (NYSE: EW) Q2 2022 Earnings Call Jul 28, 2022 , 5:00 p.m. ET Operator Continue reading For further details see: Edwards Lifesciences (EW) Q2 2022 Earnings Call Transcript
News, Short Squeeze, Breakout and More Instantly...
Edwards Lifesciences Corporation Company Name:
EW Stock Symbol:
NYSE Market:
Edwards Lifesciences Corporation Website:
Vancouver, British Columbia--(Newsfile Corp. - July 30, 2024) - East West Petroleum Corp. (TSXV: EW) ("East West" or the "Company") is pleased to provide this update in regard to the status of the proposed return of capital announced on June 19, 2024 . The Company has prepared and mailed its ...
A look at the top 10 most actives in the United States NVIDIA Corporation (NVDA) fell 1.7% to $112.28 on volume of 455,296,152 shares Ford Motor Company (F) fell 18.4% to $11.16 on volume of 256,384,806 shares PROSHARES TRUST (SQQQ) rose 3.4% to $9.37 on volume of 246,885,889 shares Sel...
2024-07-25 16:00:08 ET Pito Chickering from Deutsche Bank issued a price target of $85.00 for EW on 2024-07-25 13:36:00. The adjusted price target was set to $85.00. At the time of the announcement, EW was trading at $60.58. The overall price target consensus is at $109....